Crescent Pharma Limited is recalling Ramipril 2.5mg capsules after a packaging error left some cartons with blister strips of a higher dose, prompting a warning to pharmacies and healthcare professionals to stop supplying the affected batch. The batch number named in the alert is GR155023.

The Medicines and Healthcare products Regulatory Agency said the recall followed a healthcare professional finding a sealed carton that contained two blister strips of Ramipril 10mg capsules. In some cases, cartons labelled as Ramipril 2.5mg capsules may contain blister strips marked as Ramipril 10mg capsules, creating a risk that patients could receive a stronger dose than intended.

The agency said both product batches were manufactured at the same site and that the error appears to have happened during packaging of the cartons rather than in the medicine itself. Pharmacies and healthcare professionals have been told to stop supplying the impacted batch and return all remaining stock to their suppliers.

Ramipril is a commonly prescribed medicine used to treat high blood pressure, kidney disease and heart failure. Because it lowers blood pressure and affects kidney function, taking more than the required dose can cause fainting, fatigue or altered kidney function.

Dr Alison Cave said anyone taking Crescent Pharma Limited Ramipril 2.5mg capsules should check the outer carton for batch number GR155023 and make sure the strength printed on the carton matches the blister strips inside. If the carton contains correctly labelled Ramipril 2.5mg blister strips, she said there is no need to take any further action and the medicine can continue as usual.

She added that if someone has received an affected pack and believes they may have taken any Ramipril 10mg capsules included in error, medical advice should be sought if side effects are being experienced. The warning is a recall tied to a packaging mistake, not a problem with the drug itself, but the advice now is to check every pack from the batch before it is used.